V. Gaberc‐Porekar

440 total citations
27 papers, 358 citations indexed

About

V. Gaberc‐Porekar is a scholar working on Molecular Biology, Ecology, Evolution, Behavior and Systematics and Pharmacology. According to data from OpenAlex, V. Gaberc‐Porekar has authored 27 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Ecology, Evolution, Behavior and Systematics and 4 papers in Pharmacology. Recurrent topics in V. Gaberc‐Porekar's work include Plant and fungal interactions (10 papers), Protein purification and stability (5 papers) and Analytical Chemistry and Chromatography (4 papers). V. Gaberc‐Porekar is often cited by papers focused on Plant and fungal interactions (10 papers), Protein purification and stability (5 papers) and Analytical Chemistry and Chromatography (4 papers). V. Gaberc‐Porekar collaborates with scholars based in Slovenia, China and United States. V. Gaberc‐Porekar's co-authors include Viktor Menart, Simona Jevševar, Djuro Josić, Primož Pristovšek, Marjana Novič, Marjan Bele, Milena Zorko, P. Venturini, Darko Makovec and J. Jamnik and has published in prestigious journals such as Journal of Chromatography A, Applied Microbiology and Biotechnology and Journal of Immunological Methods.

In The Last Decade

V. Gaberc‐Porekar

26 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Gaberc‐Porekar Slovenia 10 234 92 74 60 41 27 358
Nermin Fornstedt Sweden 7 366 1.6× 70 0.8× 56 0.8× 131 2.2× 9 0.2× 11 575
Silvana L. Giudicessi Argentina 13 248 1.1× 98 1.1× 31 0.4× 92 1.5× 7 0.2× 34 432
JohnM. Walker 6 264 1.1× 61 0.7× 38 0.5× 102 1.7× 4 0.1× 6 393
Yifeng Xu China 11 125 0.5× 51 0.6× 41 0.6× 22 0.4× 7 0.2× 19 321
Ryoji Kimura Japan 14 153 0.7× 38 0.4× 48 0.6× 14 0.2× 5 0.1× 27 422
Bo Skoog Sweden 8 186 0.8× 29 0.3× 88 1.2× 71 1.2× 3 0.1× 14 412
Assem Elkak Lebanon 13 290 1.2× 159 1.7× 110 1.5× 54 0.9× 3 0.1× 27 495
R. H. Saundry United Kingdom 4 192 0.8× 27 0.3× 33 0.4× 43 0.7× 3 0.1× 5 417
Charng‐Sheng Tsai Taiwan 6 262 1.1× 47 0.5× 47 0.6× 17 0.3× 4 0.1× 8 331

Countries citing papers authored by V. Gaberc‐Porekar

Since Specialization
Citations

This map shows the geographic impact of V. Gaberc‐Porekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Gaberc‐Porekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Gaberc‐Porekar more than expected).

Fields of papers citing papers by V. Gaberc‐Porekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Gaberc‐Porekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Gaberc‐Porekar. The network helps show where V. Gaberc‐Porekar may publish in the future.

Co-authorship network of co-authors of V. Gaberc‐Porekar

This figure shows the co-authorship network connecting the top 25 collaborators of V. Gaberc‐Porekar. A scholar is included among the top collaborators of V. Gaberc‐Porekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Gaberc‐Porekar. V. Gaberc‐Porekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caserman, Simon, et al.. (2008). A novel reporter gene assay for interferons based on CHO-K1 cells. Journal of Immunological Methods. 333(1-2). 192–196. 9 indexed citations
2.
Gaberc‐Porekar, V., et al.. (2008). Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin–Sepharose affinity chromatography. Journal of Chromatography B. 867(1). 119–125. 19 indexed citations
3.
Bele, Marjan, Stanislav Čampelj, Darko Makovec, et al.. (2008). Zinc-decorated silica-coated magnetic nanoparticles for protein binding and controlled release. Journal of Chromatography B. 867(1). 160–164. 27 indexed citations
4.
Pristovšek, Primož, et al.. (2007). Chemometric Approach in Quantification of Structural Identity/Similarity of Proteins in Biopharmaceuticals.. ChemInform. 38(33). 1 indexed citations
5.
Gaberc‐Porekar, V., et al.. (2005). Characterisation of metal–chelate methacrylate monoliths. Journal of Chromatography A. 1109(1). 80–85. 22 indexed citations
6.
Gaberc‐Porekar, V. & Viktor Menart. (2005). Potential for Using Histidine Tags in Purification of Proteins at Large Scale. Chemical Engineering & Technology. 28(11). 1306–1314. 106 indexed citations
7.
Gaberc‐Porekar, V., et al.. (1999). Histidines in affinity tags and surface clusters for immobilized metal-ion affinity chromatography of trimeric tumor necrosis factor α. Journal of Chromatography A. 852(1). 117–128. 36 indexed citations
8.
Novaković, Srdjan, et al.. (1997). NEW TNF-α ANALOGUES: A POWERFUL BUT LESS TOXIC BIOLOGICAL TOOL AGAINST TUMOURS. Cytokine. 9(8). 597–604. 10 indexed citations
9.
Menart, Viktor, et al.. (1996). Searching for new TNF-α analogs having potential application in cancer therapy. Pflügers Archiv - European Journal of Physiology. 431(S6). R233–R234. 3 indexed citations
10.
Gaberc‐Porekar, V., et al.. (1996). Relationship between theClavicepsLife Cycle and Productivity of Ergot Alkaloids. Critical Reviews in Biotechnology. 16(3). 257–299. 6 indexed citations
11.
Menart, Viktor, et al.. (1994). Purification of human tumour necrosis factor by membrane chromatography. Journal of Chromatography A. 661(1-2). 161–168. 33 indexed citations
12.
Gaberc‐Porekar, V., et al.. (1991). Activation of ergot alkaloid biosynthesis in prototrophic isolates by protoplast fusion. Journal of Biotechnology. 20(3). 271–278. 2 indexed citations
13.
Gaberc‐Porekar, V., et al.. (1991). Characterization of sectored colonies of a high‐yielding Claviceps purpurea strain. Journal of Basic Microbiology. 31(1). 27–35. 3 indexed citations
14.
Gaberc‐Porekar, V., et al.. (1989). The effect of aeration and agitation on Claviceps purpurea dimorphism and alkaloid synthesis during submerged fermentation. Applied Microbiology and Biotechnology. 31(2). 134–137. 5 indexed citations
15.
Gaberc‐Porekar, V., et al.. (1987). Metabolic changes in a conidia-induced Claviceps paspali strain during submerged fermentation. Canadian Journal of Microbiology. 33(7). 602–606. 3 indexed citations
16.
Gaberc‐Porekar, V., et al.. (1985). Biochemical characterization of the inoculum of Claviceps purpurea for submerged production of ergot alkaloids. Applied Microbiology and Biotechnology. 21-21(1-2). 91–95. 10 indexed citations
17.
Gaberc‐Porekar, V., et al.. (1982). Transformation of tomatidine by Gymnoascus reesii. Zeitschrift für allgemeine Mikrobiologie. 22(6). 359–363. 3 indexed citations
18.
Gaberc‐Porekar, V., et al.. (1982). Transformation of tomatidine byGymnoascus reesii. Journal of Basic Microbiology. 22(6). 359–363. 1 indexed citations
19.
Gaberc‐Porekar, V., et al.. (1981). Direct thin-layer densitometric determination of citric acid in fermentation media. Analytical and Bioanalytical Chemistry. 309(2). 114–116. 3 indexed citations
20.
Gaberc‐Porekar, V., et al.. (1980). Micromethod for the quantitative determination of succinic acid in the fermentation media. Applied Microbiology and Biotechnology. 9(1). 53–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026